Antiphospholipid Syndrome (APS) and Livedoid Vasculopathy (LV)
Overview Antiphospholipid Syndrome (APS) is a systemic autoimmune condition characterized by an increased tendency for blood clot formation (thrombosis). It is often associated with Systemic Lupus Erythematosus and may occur as a secondary condition in lupus patients. Although APS is not formally classified as a systemic vasculitis, it is best described as a thrombo-inflammatory disorder. Its hallmark is non-inflammatory vascular injury caused by clotting, but it can sometimes mimic or overlap with vasculitic diseases. Livedoid Vasculopathy (LV), on the other hand, is a rare, chronic, and painful thrombo-occlusive disease that primarily affects the small blood vessels of the skin, especially in the lower legs. Despite its name, LV is not a true inflammatory vasculitis but rather a disorder driven by microvascular thrombosis. APS and Vasculitis: Overlap and Distinction A key challenge in clinical practice is distinguishing APS from true vasculitis: Different mechanisms :...